BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15767916)

  • 1. [Low-grade endometrial stromal sarcoma: contribution of hormone therapy and etoposide].
    Paillocher N; Lortholary A; Abadie-Lacourtoisie S; Morand C; Verriele V; Catala L; Descamps P
    J Gynecol Obstet Biol Reprod (Paris); 2005 Feb; 34(1 Pt 1):41-6. PubMed ID: 15767916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report.
    Akashi D; Todo Y; Shimada C; Okamoto K; Minobe S; Kato H
    Jpn J Clin Oncol; 2013 Nov; 43(11):1145-9. PubMed ID: 24058200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal therapy of endometrial stromal sarcoma.
    Reich O; Regauer S
    Curr Opin Oncol; 2007 Jul; 19(4):347-52. PubMed ID: 17545798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged stabilization of progressive endometrial stromal sarcoma with prolonged oral etoposide therapy.
    Lin YC; Kudelka AP; Tresukosol D; Malpica A; Carrasco CH; Lawrence DD; Collier RE; Munoz A; Delclos L; Kavanagh JJ
    Gynecol Oncol; 1995 Aug; 58(2):262-5. PubMed ID: 7622117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor.
    Leiser AL; Hamid AM; Blanchard R
    Gynecol Oncol; 2004 Aug; 94(2):567-71. PubMed ID: 15297205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma.
    Cade TJ; Quinn MA; Rome RM; Polyakov A
    Aust N Z J Obstet Gynaecol; 2014 Oct; 54(5):453-6. PubMed ID: 25287561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report.
    Maeda O; Moritani S; Ichihara S; Inoue T; Ishihara Y; Yamamoto S; Ito M; Matsumura Y; Sugiyama K; Horio M; Kondo I
    J Med Case Rep; 2015 Oct; 9():233. PubMed ID: 26481040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of oophorectomy and hormone suppression in low grade endometrial stromal sarcoma: A multicenter review.
    Stewart LE; Beck TL; Giannakopoulos NV; Rendi MH; Isacson C; Goff BA
    Gynecol Oncol; 2018 May; 149(2):297-300. PubMed ID: 29534832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatase inhibitor therapy for endometrial stromal sarcoma - two-centre experience.
    Serkies K; Abacjew-Chmyłko A; Wieczorek-Rutkowska M; Pęksa R
    Ginekol Pol; 2018; 89(11):607-610. PubMed ID: 30508212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
    Feng W; Hua K; Malpica A; Zhou X; Baak JP
    Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study.
    Dahhan T; Fons G; Buist MR; Ten Kate FJ; van der Velden J
    Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):80-4. PubMed ID: 19269732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue.
    Burke C; Hickey K
    Obstet Gynecol; 2004 Nov; 104(5 Pt 2):1182-4. PubMed ID: 15516445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine sarcoma Part II-Uterine endometrial stromal sarcoma: The TAG systematic review.
    Horng HC; Wen KC; Wang PH; Chen YJ; Yen MS; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):472-9. PubMed ID: 27590366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy and hormone therapy for uterine sarcomas].
    Yamashita H; Arai H; Aoki D
    Gan To Kagaku Ryoho; 2012 May; 39(5):722-5. PubMed ID: 22584323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic therapy for endometrial stromal sarcomas: current treatment options.
    Serkies K; Pawłowska E; Jassem J
    Ginekol Pol; 2016; 87(8):594-7. PubMed ID: 27629136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Grade Endometrial Stromal Sarcoma - a Review.
    Thiel FC; Halmen S
    Oncol Res Treat; 2018; 41(11):687-692. PubMed ID: 30317238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial stromal sarcoma: a rare entity.
    Jabeen S; Anwar S; Fatima N
    J Coll Physicians Surg Pak; 2015 Mar; 25(3):216-7. PubMed ID: 25772965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Anterior Pelvic Exenteration with Super Radical Parametrectomy for a Recurrent Low-Grade Endometrial Sarcoma That is Resistant to Hormone Therapy and Chemotherapy.
    Kanao H; Hisa T; Omi M; Nagashima M; Okamoto S; Aoki Y; Tanigawa T; Matoda M; Okamoto S; Nomura H; Omatsu K; Kato K; Utsugi K; Takeshima N
    J Minim Invasive Gynecol; 2019 Jan; 26(1):34-35. PubMed ID: 29621612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.